IDT Australia Ltd (ASX: IDT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

IDT Australia Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $30.93 million
P/E Ratio 14.45
Dividend Yield 0.00%
Shares Outstanding 351.48 million
Earnings per share -0.022
Dividend per share N/A
Year To Date Return -20.91%
Earnings Yield 6.92%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • IDT Australia Ltd (ASX: IDT)
    Latest News

    A female scientist sits at her desk looking stressed out while working in an AnteoTech lab.
    Healthcare Shares

    How did ASX biotech shares perform in FY22?

    Biotech certainly wasn't immune to market pressures in FY22.

    Read more »

    A woman screams and holds her hands up in frustration.
    Healthcare Shares

    Why the IDT Australia (ASX:IDT) share price is crashing 37% lower today

    IDT shares are being hammered today...

    Read more »

    a medical person in full protective clothing holds a tray of Covid-19 vaccinations amid a haze caused by cold and ice.
    Healthcare Shares

    Why is the IDT (ASX:IDT) share price halted today?

    Trading in the pharmaceutical manufacturer is on hold pending an announcement.

    Read more »

    asx share price swing represented by old lady on swing
    Healthcare Shares

    IDT (ASX:IDT) share price swings as CEO lauds mRNA tech in fight against Omicron

    Vaccine manufacturers are racing to get ahead of the fast-mutating coronavirus.

    Read more »

    Starpharma share price A doctor or medical expert in COVID-19 protection flexes his muscle, indicating growth or strong share price movement in ASX medical, biotech and health companies
    Share Market News

    The Starpharma (ASX: SPL) share price surges on Vietnam launch

    The Starpharma Holdings Limited (ASX: SPL) share price is racing ahead this morning after confirming its antiviral nasal spray will…

    Read more »

    A drawing of a white rocket streaking up, indicating a surging share pirce movement
    Healthcare Shares

    IDT Australia (ASX:IDT) share price rockets 40% on COVID vaccine update

    What did IDT Australia update the ASX with?

    Read more »

    a medical researcher holds a vial of vaccine with a needle inserted in the top watching intently behind a mask and goggles and protective medical clothing.
    Share Gainers

    Here's why the IDT Australia (ASX:IDT) share price is up 75% in a month.

    IDT shares have soared well into the green over the last month.

    Read more »

    A drawing of a rocket follows a chart up, indicating share price lift
    Share Gainers

    IDT Australia (ASX: IDT) share price surges 16% on vaccine government talks

    IDT shares are well on the move this morning after a key update.

    Read more »

    A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
    Healthcare Shares

    Why the IDT (ASX:IDT) share price is rocketing 25% on Wednesday

    The company claims it can make 100 million doses of mRNA vaccine within 18 months.

    Read more »

    A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
    Share Gainers

    Why the IDT Australia (ASX:IDT) share price is storming 19% higher today

    This company could be about to help Australia fight back against COVID-19...

    Read more »

    asx share price increase represented by golden dollar sign rocketing out from white domes of lithium
    Share Gainers

    Why the IDT Australia (ASX:IDT) share price is up 150% in just 2 days

    The IDT Australia Limited (ASX:IDT) share price was on fire again on Monday and stretched its two-day return to a…

    Read more »

    covid asx share price represented by man in face mask giving thumbs up
    Share Market News

    Why COVID-19 is launching the IDT Australia (ASX:IDT) share price 65%

    The IDT Australia (ASX:ITD) share price is soaring on news the company has been asked whether it is capable of…

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    08 May 2006 $0.0350 100.00% Interim 26 May 2006
    30 Sep 2005 $0.0450 100.00% Final 21 Oct 2005
    08 Apr 2004 $0.0300 100.00% Interim 30 Apr 2004

    IDT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About IDT Australia Ltd

    IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services.

    IDT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    11 Apr 2024 $0.09 $0.00 0.00% 35,950 $0.09 $0.09 $0.09
    10 Apr 2024 $0.09 $0.00 0.00% 43,480 $0.08 $0.09 $0.08
    09 Apr 2024 $0.08 $0.00 0.00% 202,222 $0.09 $0.09 $0.08
    08 Apr 2024 $0.09 $0.01 12.99% 457,001 $0.08 $0.09 $0.08
    05 Apr 2024 $0.08 $-0.01 -12.20% 80,561 $0.08 $0.08 $0.08
    04 Apr 2024 $0.08 $0.01 12.99% 134,316 $0.08 $0.08 $0.08
    03 Apr 2024 $0.08 $0.00 0.00% 444,225 $0.08 $0.08 $0.08
    02 Apr 2024 $0.08 $0.00 0.00% 17,997 $0.08 $0.08 $0.08
    28 Mar 2024 $0.08 $0.00 0.00% 44,183 $0.08 $0.08 $0.08
    27 Mar 2024 $0.08 $0.00 0.00% 51,825 $0.08 $0.08 $0.08
    26 Mar 2024 $0.08 $0.00 0.00% 74,780 $0.08 $0.08 $0.08
    25 Mar 2024 $0.08 $0.00 0.00% 84,571 $0.08 $0.08 $0.08
    22 Mar 2024 $0.08 $0.00 0.00% 115,744 $0.08 $0.08 $0.08
    21 Mar 2024 $0.08 $0.00 0.00% 67,756 $0.08 $0.08 $0.08
    20 Mar 2024 $0.08 $0.00 0.00% 151,022 $0.08 $0.08 $0.08
    19 Mar 2024 $0.08 $0.00 0.00% 148,990 $0.08 $0.08 $0.08
    18 Mar 2024 $0.08 $0.00 0.00% 286,063 $0.08 $0.08 $0.08
    15 Mar 2024 $0.08 $0.00 0.00% 5,075 $0.08 $0.09 $0.08
    14 Mar 2024 $0.08 $0.00 0.00% 35,334 $0.08 $0.08 $0.08
    13 Mar 2024 $0.08 $0.00 0.00% 107,077 $0.08 $0.08 $0.08

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    21 Dec 2023 Geoffrey Sam Buy 78,720 $8,265
    On-market trade.
    20 Dec 2023 Geoffrey Sam Buy 158,072 $16,505
    On-market trade.
    07 Aug 2023 Jane Ryan Issued 3,000,000 $195,000
    Issue of options.
    07 Aug 2023 Geoffrey Sam Issued 3,000,000 $195,000
    Issue of options.
    07 Aug 2023 Mark Simari Issued 6,000,000 $390,000
    Issue of options.
    21 Jul 2023 Mark Simari Buy 230,770 $15,000
    Participation in share purchase plan.
    21 Jul 2023 Geoffrey Sam Buy 461,539 $30,000
    Participation in share purchase plan.
    04 May 2023 Jane Ryan Transfer 79,366 $5,000
    Off-market transfer.
    04 May 2023 Mark Simari Transfer 355,206 $22,378
    Off-market transfer.
    04 May 2023 Geoffrey Sam Transfer 355,206 $22,378
    Off-market transfer.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Mark Anthony Simari Non-Executive Director Oct 2022
    Mr Simari is an experienced professional in the health industry and has over 15 years of Board experience in a diverse range of organisations. He was instrumental in Paragon Care becoming one of the largest independent healthcare suppliers in the Australian and New Zealand Markets, creating a healthcare platform spanning across capital equipment, consumables, devices and service and maintenance. He is Executive Director of Careteq Limited and Non-Executive Director of Tali Digital Limited and also a chairman of risk committee.
    Mr Geoffrey Joseph Sam Non-Executive Director Oct 2022
    Mr Sam has held previous independent Non-executive Board positions with listed companies Money 3 Ltd, Hutchinsons Childcare Services Ltd and was Managing Director of Nova Health Ltd. He is the Co-Founder and Board member of Healthe Care Australia Pty Ltd, a privately owned health care company comprising a portfolio of 18 hospitals. He is Non-Executive Director of Earlypay Ltd, Paragon Care Ltd and Change Financial Ltd. He is member of risk committee.
    Dr Jane Ryan Non-Executive Director Jan 2022
    Dr Ryan has over 30 years of international experience in the pharmaceutical and biotechnology industries where she has held executive roles in management of research and development programs as well as business development and alliance management. Jane has worked in Australia, the United States and United Kingdom. Throughout her career, she has led many fundraising campaigns and licensing. He is a Non-Executive Director of Anatara Lifesciences Ltd and Bionomics Ltd. She is a Member of Risk Committee.
    Mr Mark Andrew Licciardo Company Secretary Oct 2022
    -
    Mr Paul Joseph Mcdonald Chief Executive Officer Sep 2022
    -
    Dr David Sparling Joint Company Secretary Feb 2018
    -
    Ms Ancila Desai Chief Financial OfficerJoint Company Secretary Jun 2020
    -
    Paul Joseph Mcdonald Chief Executive Officer
    -
    Ancila Desai Chief Financial OfficerJoint Company Secretary
    -
    Mark Andrew Licciardo Company Secretary
    -
    David Sparling Joint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    One Managed Invt Funds Ltd and Sandon Capital Inv Ltd A/C 32,408,366 8.19%
    Merrill Lynch (Australia) Nominees Pty Limited 23,682,196 5.98%
    HSBC Custody Nominees (Australia) Limited 23,554,937 5.95%
    One Fund Services Ltd and Sandon Capital Inv Ltd A/C 18,933,201 4.78%
    Ubs Nominees Pty Ltd 13,755,534 3.47%
    Citicorp Nominees Pty Limited 9,978,904 2.52%
    Mr Anthony John Huntley 9,690,316 2.45%
    Invia Custodian Pty Limited and Graeme Leslie Blackman A/C 6,029,710 1.52%
    Keiser Investments Pty Ltd and Gann Family Retirement A/C 5,502,672 1.39%
    Picherit'S Farm Pty Ltd and Huntley Super Fund A/C 5,280,723 1.33%
    Mr Robert Darius Fraser and Fraser Family A/C 3,990,331 1.01%
    Invia Custodian Pty Limited and Paulene Blackman A/C 3,457,737 0.87%
    Buttonwood Nominees Pty Ltd 3,000,000 0.76%
    Ms Melissa Mary Stephens 2,961,539 0.75%
    Warbont Nominees Pty Ltd and Unpaid Entrepot A/C 2,650,752 0.67%
    Paul Mcdonald 2,616,539 0.66%
    On On For Don Pty Ltd and Mac Family A/C 2,461,539 0.62%
    Neweconomy Com Au Nominees Pty Limited and 900 Account 2,373,299 0.60%
    Mr Alistair David Strong 2,153,847 0.54%
    Tide Rider Pty Ltd 2,086,539 0.53%

    Profile

    since

    Note